Track Electromed, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Electromed, Inc. ELMD · Stock Open Electromed, Inc. in new tab

24.32 USD
P/E
17.62
EPS
1.38
P/B
3.82
ROE
24.54
Beta
0.44
Target Price
48.50 USD
Electromed, Inc. logo

Electromed, Inc.

🧾 Earnings Recap – Q1 2027

Electromed shares fell 8.2% after earnings, despite higher revenue and operating income. The likely concern is the sharp contraction in distributor and hospital revenue, which tempers the 17.6% growth in the core home-care channel; the supplied transcript provides no updated guidance to explain the market’s reaction.

  • Q1 revenue rose 10.6% year over year to $18.7 million; operating income increased 30.7% to $3.5 million.
  • Diluted EPS was $0.32, up 28% from $0.25 a year earlier.
  • Home-care revenue grew 17.6% and accounted for 94% of revenue. Distributor revenue fell 56%, while hospital revenue declined 32%.
  • Electromed ended the quarter with 63 direct home-care sales representatives and four open territories; it also renewed its contract with the largest hospital GPO in the country.
  • SmartOrder handled 48% of Q1 orders, which shipped about five days faster than fax-based orders.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 9, 2027
P/E17.62
EPS1.38
Book Value6.37
Price to Book3.82
Debt/Equity0.10
% Insiders17.549%
Growth
Revenue Growth0.11%
Earnings Growth0.28%
Estimates
Forward P/E39.87
Forward EPS0.61
Target Mean Price48.50

DCF valuation

Model fair value for Electromed, Inc. (ELMD)
Result
Sign in to run the valuation for ELMD.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
2 analysts · consensus Strong buy · mean target 48.50 USD (low 47.00, high 50.00) · as of 16 Nov 2026
Low 47.00
Mean 48.50
High 50.00
Price 24.32
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Electromed, Inc. Logo Electromed, Inc. Analysis (ELMD)

United States Health Care Official Website Stock

Is Electromed, Inc. a good investment? Electromed, Inc. (ELMD) is currently trading at 24.32 USD. Market analysts have a consensus price target of 48.50 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 17.62. This valuation is generally in line with the broader market.

Earnings Schedule: Electromed, Inc. is expected to release its next earnings report on Feb. 9, 2027. The market consensus estimate for Forward EPS is 0.61.

Investor FAQ

Does Electromed, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Electromed, Inc.?

Electromed, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 9, 2027. The company currently has a trailing EPS of 1.38.

Company Profile

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Exchange Ticker
ASE (United States) ELMD
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion